Updated Jul 16, 2026
Venkatesan Jay has filed 2 SEC Form 4 filings across 1 company in the last 90 days — buying. Lifetime open-market purchases: $1K.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-22 | SER | Serina Therapeutics, Inc. | J — Other acquisition / disposition | 224.2K | $2.25 | $504K |
| 2026-06-22 | SER | Serina Therapeutics, Inc. | P — Open-market purchase | 589 | $1.78 | $1K |
| 2026-04-21 | SER | Serina Therapeutics, Inc. | A — Grant or award | 7.6K | $1.94 | $15K |
| 2024-11-29 | ELTX | Elicio Therapeutics, Inc. | J — Other acquisition / disposition | 50.0K | $0.01 | $500 |
Venkatesan Jay is a corporate insider — currently tracked as Director of Serina Therapeutics, Inc. (SER). InsiderAlpha tracks every SEC Form 4 filing in real time.
2 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 1 open-market purchases ($1K) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Venkatesan Jay profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.